Assessment of Gastrointestinal Clinical and Laboratory Features and Their Prognostic Implications in Hospitalized COVID-19 Patients: A Prospective Cohort Analysis - Top-Institutions - MDSpire

Assessment of Gastrointestinal Clinical and Laboratory Features and Their Prognostic Implications in Hospitalized COVID-19 Patients: A Prospective Cohort Analysis

  • By

  • Thiago Henrique Fernandes de Carvalho

  • Fabyan Beltrão Esberard

  • Maryana Cavalcanti Holanda

  • Matheus Venâncio de Paiva

  • Daniele Carvalhal de Almeida Beltrão

  • Giulia Carvalhal

  • José Felipe Lacerda Fernandes

  • Carlos Alexandre Antunes de Brito

  • February 13, 2026

  • 0 min

Share

Top Institutions in Pulmonary

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Gastroenterology
    • Infectious Diseases
    • Epidemiology

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Gastroenterology
    • Hepatology
    • Infectious Diseases

  • #3

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Gastroenterology
    • Hepatology
    • Infectious Diseases

  • #4

    University of São Paulo Medical School
    University of São Paulo Medical School

    São Paulo, SP

    Key Differentiators

    • Gastroenterology
    • Infectious Diseases
    • Epidemiology

  • #5

    Imperial College London
    Imperial College London

    London, N/A

    Key Differentiators

    • Gastroenterology
    • Infectious Diseases
    • Epidemiology

Original Source(s)

Assessment of Gastrointestinal Clinical and Laboratory Features and Their Prognostic Implications in Hospitalized COVID-19 Patients: A Prospective Cohort Analysis

  • by Thiago Henrique Fernandes de Carvalho, Fabyan Beltrão Esberard, Maryana Cavalcanti Holanda, Matheus Venâncio de Paiva, Daniele Carvalhal de Almeida Beltrão, Giulia Carvalhal, José Felipe Lacerda Fernandes, Carlos Alexandre Antunes de Brito

  • February 13, 2026

Related Content

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.

Bereavement Tied to Higher Cardiovascular Risk

Acute post-loss period and pandemic conditions each amplified cardiovascular vulnerability in nationwide Swedish cohort study.

Equity and representation in oncology clinical evidence for FDA-approved treatments and the impact of COVID-19